Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 0 | 0 | 0 | 0 | -3,300 |
| Cost of Goods | N/A | N/A | N/A | 697 | 890 |
| Gross Profit | N/A | N/A | N/A | -697 | -4,190 |
| Operating Expenses | 61,369 | 48,001 | 43,993 | 25,732 | 45,525 |
| Operating Income | -61,369 | -48,001 | -43,993 | -25,732 | -48,825 |
| Interest Expense | 16,212 | 15,791 | 16,024 | 12,913 | 12,313 |
| Other Income | 3,597 | 3,744 | 155 | -9,160 | -6,563 |
| Pre-tax Income | -73,984 | -60,048 | -59,862 | -47,805 | -67,701 |
| Income Tax | 10 | 7 | 3 | -3,513 | -16,066 |
| Net Income Continuous | -73,994 | -60,055 | -59,865 | -44,292 | -51,635 |
| Net Income Discontinuous | N/A | N/A | N/A | 1,818 | -3,999 |
| Net Income | $-73,994 | $-60,055 | $-59,865 | $-42,474 | $-55,634 |
| EPS Basic Total Ops | -0.92 | -0.80 | -0.80 | -0.58 | -0.75 |
| EPS Basic Continuous Ops | -0.92 | -0.80 | -0.80 | -0.61 | -0.70 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.03 | -0.05 |
| EPS Diluted Total Ops | -0.92 | -0.80 | -0.80 | -0.58 | -0.75 |
| EPS Diluted Continuous Ops | -0.92 | -0.80 | -0.80 | -0.61 | -0.70 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.03 | -0.05 |
| EPS Diluted Before Non-Recurring Items | -0.92 | -0.71 | -0.68 | -0.67 | -0.74 |
| EBITDA(a) | $-51,386 | $-38,431 | $-34,331 | $-20,349 | $-41,296 |